Nutriband Innovates to Enhance Safety of Transdermal Drugs with AVERSA Technology
Nutriband introduces AVERSA technology to enhance safety of transdermal drugs like fentanyl. Learn about their latest innovation and its potential impact on pharmaceuticals.
This news highlights the advancements in pharmaceutical technology to address the abuse potential of drugs like fentanyl, ultimately benefiting patients in need of these medications. By incorporating aversive agents, Nutriband's AVERSA technology could revolutionize the transdermal drug delivery landscape, offering a safer alternative for both healthcare providers and patients.